• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (from parent cell line).
  

PubMed=2787682; DOI=10.1182/blood.V74.3.940.940
Demetri G.D., Zenzie B.W., Rheinwald J.G., Griffin J.D.
Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro.
Blood 74:940-946(1989)

PubMed=15920167; DOI=10.1016/S0002-9440(10)62492-3; PMCID=PMC1363736
Gordon G.J., Rockwell G.N., Jensen R.V., Rheinwald J.G., Glickman J.N., Aronson J.P., Pottorf B.J., Nitz M.D., Richards W.G., Sugarbaker D.J., Bueno R.
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Am. J. Pathol. 166:1827-1840(2005)

PubMed=19853261; DOI=10.1016/j.jtcvs.2009.06.027
Hartman M.-L., Esposito J.M., Yeap B.Y., Sugarbaker D.J.
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
J. Thorac. Cardiovasc. Surg. 139:1233-1240(2010)